Balchem (BCPC) Stock Forecast, Price Target & Predictions
BCPC Stock Forecast
Balchem stock forecast is as follows: an average price target of $190.00 (represents a 7.45% upside from BCPC’s last price of $176.82) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
BCPC Price Target
The average price target for Balchem (BCPC) is $190.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $190.00 to $190.00. This represents a potential 7.45% upside from BCPC's last price of $176.82.
BCPC Analyst Ratings
According to 2 Wall Street analysts, Balchem's rating consensus is 'Buy'. The analyst rating breakdown for BCPC stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Balchem Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 05, 2024 | Raghuram Selvaraju | H.C. Wainwright | $190.00 | $175.31 | 8.38% | 7.45% |
| May 02, 2022 | - | H.C. Wainwright | $152.00 | $123.20 | 23.38% | -14.04% |
The latest Balchem stock forecast, released on Nov 05, 2024 by Raghuram Selvaraju from H.C. Wainwright, set a price target of $190.00, which represents a 8.38% increase from the stock price at the time of the forecast ($175.31), and a 7.45% increase from BCPC last price ($176.82).
Balchem Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 1 | 1 |
| Avg Price Target | $190.00 | $190.00 | $190.00 |
| Last Closing Price | $176.82 | $176.82 | $176.82 |
| Upside/Downside | 7.45% | 7.45% | 7.45% |
In the current month, the average price target of Balchem stock is $190.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 7.45% increase as opposed to Balchem's last price of $176.82. This month's average price target is down 0.00% compared to last quarter, and down 0.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 06, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Oct 30, 2023 | UBS | Buy | Buy | Hold |
Balchem's last stock rating was published by H.C. Wainwright on May 06, 2024. The company gave BCPC a "Buy" rating, the same as its previous rate.
Balchem Financial Forecast
Balchem Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $229.95M | $231.25M | $232.54M | $232.53M | $244.27M | $236.69M | $228.87M | $213.13M | $197.87M | $202.37M | $185.66M | $180.71M | $175.14M | $173.35M | $174.44M | $166.53M | $158.59M |
| Avg Forecast | $295.34M | $288.60M | $282.02M | $275.58M | $265.20M | $261.84M | $255.92M | $249.46M | $239.96M | $241.93M | $239.68M | $232.46M | $234.66M | $237.08M | $244.87M | $233.52M | $241.47M | $239.62M | $223.53M | $207.69M | $198.17M | $196.13M | $185.44M | $181.59M | $175.33M | $169.55M | $161.35M | $169.87M | $165.55M | $167.43M |
| High Forecast | $303.05M | $296.14M | $289.38M | $282.78M | $272.13M | $268.67M | $262.60M | $254.01M | $246.67M | $242.17M | $239.68M | $238.53M | $238.64M | $242.50M | $251.26M | $239.62M | $247.77M | $239.62M | $223.53M | $207.69M | $198.17M | $196.13M | $185.44M | $181.59M | $175.33M | $169.55M | $161.35M | $169.87M | $165.55M | $167.43M |
| Low Forecast | $288.77M | $282.18M | $275.74M | $269.45M | $259.30M | $256.01M | $250.22M | $244.91M | $233.24M | $241.69M | $239.68M | $227.28M | $230.68M | $234.30M | $239.42M | $228.32M | $236.09M | $239.62M | $223.53M | $207.69M | $198.17M | $196.13M | $185.44M | $181.59M | $175.33M | $169.55M | $161.35M | $169.87M | $165.55M | $167.43M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 0.94% | 1.00% | 0.96% | 1.02% | 1.06% | 1.10% | 1.08% | 1.01% | 1.09% | 1.02% | 1.03% | 1.03% | 1.07% | 1.03% | 1.01% | 0.95% |
Balchem's average Quarter revenue forecast for Dec 23 based on 2 analysts is $234.66M, with a low forecast of $230.68M, and a high forecast of $238.64M. BCPC's average Quarter revenue forecast represents a 2.05% increase compared to the company's last Quarter revenue of $229.95M (Sep 23).
Balchem EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $43.61M | $42.84M | $48.05M | $33.30M | $48.82M | $52.15M | $50.10M | $45.40M | $44.80M | $42.73M | $43.07M | $41.81M | $41.91M | $39.68M | $38.73M | $35.95M | $37.86M |
| Avg Forecast | $66.40M | $64.88M | $63.40M | $61.95M | $59.62M | $58.86M | $57.53M | $56.08M | $53.94M | $54.39M | $53.88M | $45.10M | $52.75M | $53.30M | $55.05M | $41.00M | $49.28M | $54.79M | $51.11M | $37.27M | $45.31M | $44.85M | $42.40M | $42.06M | $40.09M | $38.77M | $36.89M | $26.03M | $37.85M | $38.28M |
| High Forecast | $68.13M | $66.57M | $65.06M | $63.57M | $61.18M | $60.40M | $59.04M | $57.10M | $55.45M | $54.44M | $53.88M | $54.12M | $53.65M | $54.52M | $56.49M | $49.20M | $59.13M | $54.79M | $51.11M | $44.73M | $45.31M | $44.85M | $42.40M | $50.47M | $40.09M | $38.77M | $36.89M | $31.24M | $37.85M | $38.28M |
| Low Forecast | $64.92M | $63.44M | $61.99M | $60.57M | $58.29M | $57.55M | $56.25M | $55.06M | $52.43M | $54.33M | $53.88M | $36.08M | $51.86M | $52.67M | $53.82M | $32.80M | $39.42M | $54.79M | $51.11M | $29.82M | $45.31M | $44.85M | $42.40M | $33.65M | $40.09M | $38.77M | $36.89M | $20.83M | $37.85M | $38.28M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.82% | 0.78% | 1.17% | 0.68% | 0.89% | 1.02% | 1.34% | 1.00% | 1.00% | 1.01% | 1.02% | 1.04% | 1.08% | 1.08% | 1.49% | 0.95% | 0.99% |
2 analysts predict BCPC's average Quarter EBITDA for Dec 23 to be $52.75M, with a high of $53.65M and a low of $51.86M. This is 20.96% upper than Balchem's previous annual EBITDA (Sep 23) of $43.61M.
Balchem Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.07M | $30.11M | $22.71M | $21.41M | $25.25M | $29.78M | $28.93M | $24.95M | $25.01M | $22.73M | $23.41M | $22.16M | $21.57M | $21.13M | $19.77M | $20.38M | $20.68M |
| Avg Forecast | $42.29M | $42.95M | $42.29M | $41.31M | $39.34M | $40.00M | $39.67M | $39.01M | $36.23M | $36.55M | $33.93M | $26.04M | $30.49M | $31.80M | $27.54M | $23.67M | $27.08M | $30.53M | $30.69M | $21.52M | $25.47M | $27.43M | $26.77M | $22.86M | $22.36M | $21.63M | $18.17M | $13.29M | $22.53M | $21.55M |
| High Forecast | $43.73M | $44.40M | $43.73M | $42.71M | $40.67M | $41.35M | $41.01M | $41.08M | $37.45M | $37.79M | $35.08M | $31.25M | $31.19M | $34.42M | $28.47M | $28.41M | $32.49M | $30.53M | $30.69M | $25.83M | $25.47M | $27.43M | $26.77M | $27.43M | $22.36M | $21.63M | $18.17M | $15.94M | $22.53M | $21.55M |
| Low Forecast | $41.07M | $41.70M | $41.07M | $40.11M | $38.20M | $38.84M | $38.52M | $36.60M | $35.90M | $35.50M | $32.95M | $20.83M | $29.79M | $29.18M | $26.74M | $18.94M | $21.66M | $30.53M | $30.69M | $17.22M | $25.47M | $27.43M | $26.77M | $18.29M | $22.36M | $21.63M | $18.17M | $10.63M | $22.53M | $21.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.91% | 1.09% | 0.96% | 0.79% | 0.83% | 0.97% | 1.34% | 0.98% | 0.91% | 0.85% | 1.02% | 0.99% | 1.00% | 1.16% | 1.49% | 0.90% | 0.96% |
Balchem's average Quarter net income forecast for Dec 23 is $30.49M, with a range of $29.79M to $31.19M. BCPC's average Quarter net income forecast represents a 4.86% increase compared to the company's last Quarter net income of $29.07M (Sep 23).
Balchem SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $29.06M | $30.72M | $35.31M | $32.29M | $31.81M | $29.03M | $29.94M | - | $25.27M | $25.95M | $25.40M | $25.52M | $24.65M | $25.89M | $26.35M | $27.77M | $25.28M |
| Avg Forecast | $39.78M | $38.87M | $37.98M | $37.12M | $35.72M | $35.27M | $34.47M | $33.60M | $32.32M | $32.58M | $32.28M | $26.95M | $31.61M | $31.93M | $32.98M | $24.50M | $32.52M | $32.27M | $30.11M | $22.27M | $26.69M | $26.42M | $24.98M | $24.81M | $23.61M | $22.84M | $21.73M | $17.71M | $22.30M | $22.55M |
| High Forecast | $40.82M | $39.89M | $38.98M | $38.09M | $36.65M | $36.19M | $35.37M | $34.21M | $33.22M | $32.62M | $32.28M | $32.34M | $32.14M | $32.66M | $33.84M | $29.40M | $33.37M | $32.27M | $30.11M | $26.73M | $26.69M | $26.42M | $24.98M | $29.77M | $23.61M | $22.84M | $21.73M | $21.26M | $22.30M | $22.55M |
| Low Forecast | $38.89M | $38.01M | $37.14M | $36.29M | $34.92M | $34.48M | $33.70M | $32.99M | $31.41M | $32.55M | $32.28M | $21.56M | $31.07M | $31.56M | $32.25M | $19.60M | $31.80M | $32.27M | $30.11M | $17.82M | $26.69M | $26.42M | $24.98M | $19.84M | $23.61M | $22.84M | $21.73M | $14.17M | $22.30M | $22.55M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.91% | 0.93% | 1.44% | 0.99% | 0.99% | 0.96% | 1.34% | - | 0.96% | 1.04% | 1.02% | 1.08% | 1.08% | 1.19% | 1.49% | 1.25% | 1.12% |
Balchem's average Quarter SG&A projection for Dec 23 is $31.61M, based on 2 Wall Street analysts, with a range of $31.07M to $32.14M. The forecast indicates a 8.75% rise compared to BCPC last annual SG&A of $29.06M (Sep 23).
Balchem EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 2 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.91 | $0.94 | $0.71 | $0.67 | $0.79 | $0.93 | $0.90 | $0.77 | $0.78 | $0.70 | $0.73 | $0.68 | $0.67 | $0.66 | $0.62 | $0.63 | $0.64 |
| Avg Forecast | $1.29 | $1.31 | $1.29 | $1.26 | $1.20 | $1.22 | $1.21 | $1.19 | $1.10 | $1.11 | $1.03 | $0.98 | $0.93 | $0.97 | $0.84 | $0.72 | $0.80 | $0.94 | $0.94 | $0.82 | $0.78 | $0.84 | $0.82 | $0.79 | $0.69 | $0.66 | $0.56 | $0.62 | $0.69 | $0.66 |
| High Forecast | $1.33 | $1.35 | $1.33 | $1.30 | $1.24 | $1.26 | $1.25 | $1.25 | $1.14 | $1.15 | $1.07 | $1.01 | $0.95 | $1.05 | $0.87 | $0.74 | $0.83 | $0.94 | $0.94 | $0.82 | $0.78 | $0.84 | $0.82 | $0.79 | $0.69 | $0.66 | $0.56 | $0.62 | $0.69 | $0.66 |
| Low Forecast | $1.25 | $1.27 | $1.25 | $1.22 | $1.17 | $1.18 | $1.17 | $1.12 | $1.10 | $1.08 | $1.01 | $0.95 | $0.91 | $0.89 | $0.82 | $0.70 | $0.78 | $0.94 | $0.94 | $0.82 | $0.78 | $0.84 | $0.82 | $0.79 | $0.69 | $0.66 | $0.56 | $0.62 | $0.69 | $0.66 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.12% | 0.99% | 0.84% | 0.84% | 0.99% | 1.10% | 0.99% | 0.93% | 0.86% | 0.92% | 1.00% | 1.01% | 1.19% | 1.00% | 0.92% | 0.97% |
According to 2 Wall Street analysts, Balchem's projected average Quarter EPS for Dec 23 is $0.93, with a low estimate of $0.91 and a high estimate of $0.95. This represents a 2.20% increase compared to BCPC previous annual EPS of $0.91 (Sep 23).
Balchem Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| ASH | Ashland | $78.05 | $115.55 | 48.05% | Buy |
| KWR | Quaker Chemical | $168.58 | $192.50 | 14.19% | Buy |
| FUL | H.B. Fuller Company | $75.67 | $85.60 | 13.12% | Buy |
| MTX | Minerals | $81.72 | $90.00 | 10.13% | Buy |
| SXT | Sensient | $78.00 | $85.00 | 8.97% | - |
| BCPC | Balchem | $176.82 | $190.00 | 7.45% | Buy |
| CBT | Cabot | $109.18 | $108.67 | -0.47% | Hold |
| AXTA | Axalta Coating Systems | $40.66 | $38.25 | -5.93% | Buy |